Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Psychiatrie
»
Demenz
05. August 2026
Suchen
medline.ch
Demenz
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Angst- und Panikstörungen
Demenz
Depression
Essstörungen
Persönlichkeits- störungen
Schizophrenie und Psychosen
Schlafstörungen
Sexuelle Störungen
Somatoforme Störungen
Sucht
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 6355
Artikel 1 - 20 / 127084
Subcortical gray matter atrophy and iron deposition in patients with vascular dementia: a multimodal MRI study.
Front Neurosci
Yang J, Bao C, Liu X, Yan J, Li Y.
PMID: 42553336 [PubMed]
Lymphedema and Alzheimer's Disease: Connecting Through the "Peripheral-Central Lymphatic System".
Lymphat Res Biol
Wang X, Li Y, Ye J, Lian H, Li T, Wang J.
PMID: 42552845 [PubMed - as supplied by publisher]
Mapping the Evolution of Communication Partner Training for Dementia Caregivers: A Bibliometric Analysis (1981-2025).
Geriatr Gerontol Int
Maniam P, Fadzil NHM, Chui CS, Ying CS.
PMID: 42552797 [PubMed - indexed for MEDLINE]
Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort.
Alzheimers Dement
Fernández-Lebrero A, Jiménez-Balado J, García-Escobar G, Contador J, Estraguès-Gázquez I, Peraferrer-Montesinos L, Manero-Borràs RM, Gramegna LL, Viles M, Campello AR, Ortiz-Romero P, de Diego M, Del Campo M, Torres-Torronteras J, Jiménez-Moyano E, Blasco-Forniés H, Suárez-Calvet M, Ois A, Puig-Pijoan A, Navalpotro-Gómez I.
PMID: 42552750 [PubMed - indexed for MEDLINE]
Further data to address the Alzheimer's coverage with evidence development questions.
Alzheimers Dement
Boustani M, Klein EG, Zimmer JA, Wang H, Engle SE, Phipps A, Japha M, Schilling T, Hartry A, Alzheimer's Disease Neuroimaging Initiative.
PMID: 42552749 [PubMed - indexed for MEDLINE]
Interpreting evolving evidence in Alzheimer's disease: implications for dementia clinicians.
Br J Psychiatry
Koychev I, Rowe JB, Amin J, Arsland D, Archer H, Barber R, Burns A, Coulthard E, Deasy C, Dunne R, Fox N, Humphrey SH, Jenkinson J, Jones D, Kennelly S, Khan F, Krishnan MSP, Malhotra P, McFarlane B, McGuinness B, Mummery C, Pennington C, Perry JR, Raczek G, Rasmussen J, Ritchie C, Taylor JP, Underwood BR, Venkataraman AV, Raymont V.
PMID: 42552687 [PubMed - as supplied by publisher]
Super-Resolution of Through-Plane Undersampled MRIs in Alzheimer's Disease Diagnosis.
J Imaging Inform Med
Turrisi R, Cammarasana S, Paccini M, Patanè G, Alzheimer.
PMID: 42552272 [PubMed - as supplied by publisher]
Energetic crisis, mitochondrial vulnerability and disruption of lactate shuttle in Alzheimer's disease.
Int Rev Neurobiol
Baskar G, Kandasamy M.
PMID: 42552048 [PubMed - indexed for MEDLINE]
Metabolic dysregulation in Alzheimer's disease: Mechanisms, markers, and therapeutic prospects.
Int Rev Neurobiol
Mittal R, Priya, Banerjee J, Dixit A.
PMID: 42552047 [PubMed - indexed for MEDLINE]
Brain lipid dysregulation as a driver of energy metabolism failure in Alzheimer's disease.
Int Rev Neurobiol
Yadav N, Banerjee J, Tiwari M, Dixit A.
PMID: 42552046 [PubMed - indexed for MEDLINE]
Brain energy metabolism changes and neuropsychological impairment in Parkinson disease vs Alzheimer disease.
Int Rev Neurobiol
Khodadadi S, Rezaeimanesh N, Ariyae Motahar A, Yousefi F, Avateffazeli M, Montazeri-Shatouri R, Hosseini E, Sahab Negah S, Naser Moghadasi A.
PMID: 42552045 [PubMed - indexed for MEDLINE]
The Tau-mitochondria connection and its impact on cellular energy metabolism in Alzheimer's disease.
Int Rev Neurobiol
Singh AK, M R S, P S A, Krishnamoorthi S, Iyaswamy A, Durairajan SSK.
PMID: 42552044 [PubMed - indexed for MEDLINE]
The potential of HDAC inhibitors for Alzheimer's disease.
Int Rev Neurobiol
Jain V, Bharti S.
PMID: 42552043 [PubMed - indexed for MEDLINE]
Brain energy crisis in Alzheimer's and Parkinson's disease: Nanotechnology as a therapeutic strategy.
Int Rev Neurobiol
Milmile M, Singh S, Pandey A, Pawar G, Petkar P, Chander Y, Mishra R, Chawla R.
PMID: 42552042 [PubMed - indexed for MEDLINE]
A comprehensive review on therapeutics and diagnostic agents targeting acetyl and butyryl cholinesterases for AD.
Int Rev Neurobiol
Chaurasia V, Das Modak S, Singh GK, Modi G.
PMID: 42552040 [PubMed - indexed for MEDLINE]
Molecular insights of peroxisome proliferator-activated receptor-γ signalling in amyotrophic lateral sclerosis and Huntington's disease.
Int Rev Neurobiol
Venu G, A VP, Justin A.
PMID: 42552039 [PubMed - indexed for MEDLINE]
Metabolic therapeutic targets in Alzheimer's disease.
Int Rev Neurobiol
Peter L IR, Chatterjee D, Chrishone AF, Francis D.
PMID: 42552038 [PubMed - indexed for MEDLINE]
Association between PCSK9 targeted therapy and the risk of stroke and dementia: A Meta-Analysis of Randomized Controlled Trials.
Am J Med
Jaiswal V, Deb N, Latif F, Shrestha AB, Garimella V, Shama N, Jitta SR, Naz S, Kumar T, Khan S, Perone F, Mattumpuram J, Ang SP.
PMID: 42551778 [PubMed - as supplied by publisher]
Covalent small-molecule RNA targeting in Alzheimer's disease: computational strategies, challenges and opportunities.
Drug Discov Today
Kumar V, Arulsamy S, Sharma S, Kumar S, Kakoty V.
PMID: 42551552 [PubMed - as supplied by publisher]
How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer's disease?
Ageing Res Rev
Lei Y, Liu L, Tang Y.
PMID: 42551536 [PubMed - as supplied by publisher]
Artikel 1 - 20 / 127084
Seite 1 von 6355
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung